Clinical trial
Modification Of Disease Outcome In COPD
NCT00158847 · Leiden University Medical Center, Other · Terminated
Key facts
| NCT number | NCT00158847 |
|---|---|
| Title | Modification Of Disease Outcome In COPD |
| Official title | Modification of Disease Outcome in COPD. Shortterm Versus Longterm Treatment With Inhaled Corticosteroids, Either or Not Combined With a Long-Acting Beta2-Agonist. |
| Lead sponsor | Leiden University Medical Center, Other |
| Collaborators | Academisch Ziekenhuis Groningen The Netherlands Asthma Foundation Netherlands Organisation for Scientific Research GlaxoSmithKline Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Obstructive Pulmonary Disease |
| Intervention type | Drug |
| Interventions | fluticasone 500 mcg, fluticasone 500 mcg + salmeterol 50 mcg |
| Enrollment | 200 |
| Start date | Apr 1, 2000 |
| Completion | May 1, 2005 |
| First posted | Sep 12, 2005 |
| Last update posted | Jan 20, 2006 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: